Type
. Class specific anti-Mycobacterium leprae antibody assay in lepromatous leprosy (BL-LL) patients during the first two to four years of DDS treatment. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association [Internet]. 1982;50(3):271-81. Available from: http://ila.ilsl.br/pdfs/v50n3a01.pdf
Type
. [History of leprosy research in the Astrakhan district during the 18th century]. Vestnik dermatologii i venerologii. 1982;(8):72-4.
Type
. Leprosy (Hansen's disease). Otolaryngologic clinics of North America. 1982;15(3):597-611.
Type
. Improved leucocyte migration inhibition response of leucocytes from lepromatous leprosy patients with hapten modified M. leprae. Clinical and experimental immunology [Internet]. 1982;49(2):317-24. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1536491/pdf/clinexpimmunol00167-0063.pdf
Type
. Leprosy and its chemotherapy. The Journal of antimicrobial chemotherapy. 1982;10(2):81-4.
Type
. [Comparison of the stamp specimens with histopathological tissue sections of the ear lobe]. Nihon Rai Gakkai zasshi. 1982;51(3):140-5.
Type
. The use of subcellular components of BCG for studying host-Mycobacterium interaction in relation to leprosy. Annales d'immunologie. 1982;133D(1):41-59.
Type
. Solid, fragmented and granular index as one of the parameters in drug trials. Leprosy in India. 1982;54(3):448-53.
Type
. Rifampicin (RFP) trial in lepromatous leprosy. Leprosy in India. 1982;54(3):441-7.
Type
. Drug resistance and multi-drug therapy in leprosy. Leprosy in India. 1982;54(3):402-11.